Executive record

Svai Sanford

Most recent record: Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford (named as the outgoing officer), effective June 29, 2026.

2 verified records · 1 company

Career line from the records

2

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

  1. 2026-06-30TransitionRani Therapeutics Holdings, Inc.

    Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford

    Named as the outgoing officer

    effective June 29, 2026 · 8-K filed June 30, 2026 · sec.gov, Item 5.02

  2. 2026-03-2610-K signatureRani Therapeutics Holdings, Inc.

    Signed the annual report as Chief Financial Officer (Principal Financial and Accounting Officer)

    10-K filed March 26, 2026 · sec.gov

Companies

1

Rani Therapeutics Holdings, Inc.RANI

Pharmaceutical Preparations

This page lists only verified filing records that name Svai Sanford, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.